Funding and policy
Recent articles
Stories about research grants, funding models and the business of science
Latest
Long-standing theoretical neuroscience fellowship program loses financial support
Exclusive: Harvard University lays off fly database team
Quantifying funding sources across neuroscience labs
Fear and loathing on study section: Reviewing grant proposals while the system is burning
NIH cuts quash $323 million for neuroscience research and training
NIH autism database announcement raises concerns among researchers
FlyBase funding squashed amid Harvard grant terminations
Multisite connectome teams lose federal funding as result of Harvard cuts
Neuroscience needs to empower early-career researchers, not fund moon shots
‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Exclusive: Layoffs revoked at U.S. National Institute of Neurological Disorders and Stroke
After more than a month of uncertainty, 30 previously purged employees at the institute no longer face termination.
Exclusive: Layoffs revoked at U.S. National Institute of Neurological Disorders and Stroke
After more than a month of uncertainty, 30 previously purged employees at the institute no longer face termination.
Sharing Africa’s brain data: Q&A with Amadi Ihunwo
These data are “virtually mandatory” to advance neuroscience, says Ihunwo, a co-investigator of the Brain Research International Data Governance & Exchange (BRIDGE) initiative, which seeks to develop a global framework for sharing, using and protecting neuroscience data.
Sharing Africa’s brain data: Q&A with Amadi Ihunwo
These data are “virtually mandatory” to advance neuroscience, says Ihunwo, a co-investigator of the Brain Research International Data Governance & Exchange (BRIDGE) initiative, which seeks to develop a global framework for sharing, using and protecting neuroscience data.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
Federal funding cuts imperil next generation of autism researchers
As the International Society for Autism Research’s annual meeting begins, its next president reflects on a brewing crisis.
Federal funding cuts imperil next generation of autism researchers
As the International Society for Autism Research’s annual meeting begins, its next president reflects on a brewing crisis.
Expediting clinical trials for profound autism: Q&A with Matthew State
Aligning Research to Impact Autism, a new initiative funded by the Sergey Brin Family Foundation, wants to bring basic science discoveries to the clinic faster.
Expediting clinical trials for profound autism: Q&A with Matthew State
Aligning Research to Impact Autism, a new initiative funded by the Sergey Brin Family Foundation, wants to bring basic science discoveries to the clinic faster.
Explore more from The Transmitter
Altered excitatory circuits in CHD8-deficient mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 25 August.
Altered excitatory circuits in CHD8-deficient mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 25 August.
Should neuroscientists ‘vibe code’?
Researchers are developing software entirely through natural language conversations with advanced large language models. The trend is transforming how research gets done—but it also presents new challenges for evaluating the outcomes.
Should neuroscientists ‘vibe code’?
Researchers are developing software entirely through natural language conversations with advanced large language models. The trend is transforming how research gets done—but it also presents new challenges for evaluating the outcomes.
Why hype for autism stem cell therapies continues despite dead ends
After numerous tests, there is still no evidence that these experimental treatments help, so now is not the time to expand access to them.
Why hype for autism stem cell therapies continues despite dead ends
After numerous tests, there is still no evidence that these experimental treatments help, so now is not the time to expand access to them.